NYSE ARCA | ETF
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization.
Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry ("health care companies").
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 21.99% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 14.90% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 5.37% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 4.15% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 3.93% |
| RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 3.79% |
| AAVXF | ABIVAX Société Anonyme | Healthcare | Biotechnology | 3.66% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 3.55% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 3.23% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.87% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 2.45% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.44% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 2.39% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 2.36% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.32% |
| MLTX_old | Multex Com Inc | Other | Other | 2.25% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.22% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 2.21% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.20% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 1.99% |